Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Aktiv Helse Studio ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2019/12 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   5.4% 5.4% 5.4% 5.4% 5.4% 5.4% 5.4% 5.4%   Bankruptcy risk   0.8% 0.8% 2.1% 7.7% 1.9% 1.0% 9.5% 9.5%   Credit score (0-100)   92 91 66 30 70 85 26 26   Credit rating   AA A BBB BB A A BB BB   Credit limit (kDKK)   228.0 219.6 0.1 0.0 0.5 164.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2019/12 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,086 2,086 1,967 1,049 2,018 3,367 0.0 0.0   EBITDA   1,189 1,189 763 -135 1,091 2,073 0.0 0.0   EBIT   910 910 5.7 -1,016 140 1,046 0.0 0.0   Pre-tax profit (PTP)   843.0 843.0 -69.1 -1,079.6 68.5 1,056.7 0.0 0.0   Net earnings   661.0 661.0 -52.7 -840.4 54.8 825.1 0.0 0.0   Pre-tax profit without non-rec. items   843 843 -69.1 -1,080 68.5 1,057 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2019/12 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   2,584 2,584 2,900 2,322 1,962 1,560 0.0 0.0   Shareholders equity total   1,966 1,966 1,894 1,054 1,109 1,934 1,804 1,804   Interest-bearing liabilities   419 419 1,310 1,015 1,268 806 0.0 0.0   Balance sheet total (assets)   3,418 3,418 4,294 3,287 3,270 3,515 1,804 1,804   Net Debt   419 419 1,174 1,015 664 806 -1,804 -1,804     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2019/12 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,086 2,086 1,967 1,049 2,018 3,367 0.0 0.0   Gross profit growth   85.9% 0.0% -5.7% -46.7% 92.3% 66.8% -100.0% 0.0%   Employees   1 1 3 3 3 3 0 0   Employee growth %   0.0% 0.0% 200.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,418 3,418 4,294 3,287 3,270 3,515 1,804 1,804   Balance sheet change%   66.3% 0.0% 25.6% -23.5% -0.5% 7.5% -48.7% 0.0%   Added value   1,189.5 1,189.5 762.5 -135.4 1,020.6 2,073.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   923 -280 -441 -1,459 -1,312 -1,428 -1,560 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 -1.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2019/12 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   43.6% 43.6% 0.3% -96.8% 6.9% 31.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   33.3% 26.7% 0.2% -26.6% 4.5% 32.7% 0.0% 0.0%   ROI %   46.7% 35.1% 0.3% -36.4% 6.5% 41.9% 0.0% 0.0%   ROE %   48.1% 33.6% -2.7% -57.0% 5.1% 54.2% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2019/12 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   57.5% 57.5% 44.1% 32.1% 33.9% 55.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   35.2% 35.2% 154.0% -750.2% 60.9% 38.9% 0.0% 0.0%   Gearing %   21.3% 21.3% 69.1% 96.3% 114.4% 41.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   15.9% 16.6% 9.0% 6.0% 6.8% 5.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2019/12 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.7 0.7 0.8 0.5 0.6 1.4 0.0 0.0   Current Ratio   0.7 0.7 0.8 0.5 0.6 1.4 0.0 0.0   Cash and cash equivalent   0.0 0.0 135.5 0.0 604.2 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2019/12 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -400.1 -400.1 -294.0 -995.4 -823.0 552.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2019/12 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   1,189 1,189 254 -45 340 691 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   1,189 1,189 254 -45 364 691 0 0   EBIT / employee   910 910 2 -339 47 349 0 0   Net earnings / employee   661 661 -18 -280 18 275 0 0